Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 2Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 5Head & Neck 5Other hematologic neoplasm 3Gastrointestinal 3Thoracic 1Plasma cell 1

Conditions

Esophageal Squamous Cell Carcinoma 1Carcinoma, Hepatocellular 1Advanced Gastric Cancer 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × CF regimen × Gastrointestinal × Clear all
NCT04550260 2026-05-13

KUNLUN

AstraZeneca

Phase 3 Active not recruiting
640 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT01834963 2018-05-18

P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma.

Kansai Hepatobiliary Oncology Group

Phase 2 Unknown
66 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00992199 2010-09-08

IPchemo-AGC

Fudan University

Phase 2 Unknown
79 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡